nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftazidime—SLC15A2—melanoma	0.736	1	CbGaD
Ceftazidime—SLC22A5—Dactinomycin—melanoma	0.151	1	CbGbCtD
Ceftazidime—Local reaction—Bleomycin—melanoma	0.00201	0.0192	CcSEcCtD
Ceftazidime—Nephropathy toxic—Bleomycin—melanoma	0.00194	0.0185	CcSEcCtD
Ceftazidime—Reaction gastrointestinal—Docetaxel—melanoma	0.00187	0.0178	CcSEcCtD
Ceftazidime—Nephropathy toxic—Carmustine—melanoma	0.0017	0.0161	CcSEcCtD
Ceftazidime—Oral candidiasis—Carmustine—melanoma	0.00153	0.0146	CcSEcCtD
Ceftazidime—Encephalopathy—Carmustine—melanoma	0.00152	0.0144	CcSEcCtD
Ceftazidime—Oral candidiasis—Temozolomide—melanoma	0.00148	0.0141	CcSEcCtD
Ceftazidime—Cholestasis—Temozolomide—melanoma	0.00124	0.0118	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.0012	0.0114	CcSEcCtD
Ceftazidime—Injection site pain—Carmustine—melanoma	0.00119	0.0113	CcSEcCtD
Ceftazidime—Eosinophilia—Vemurafenib—melanoma	0.00114	0.0109	CcSEcCtD
Ceftazidime—Skin exfoliation—Bleomycin—melanoma	0.00106	0.0101	CcSEcCtD
Ceftazidime—Hyperbilirubinaemia—Temozolomide—melanoma	0.00103	0.00984	CcSEcCtD
Ceftazidime—Infestation NOS—Vemurafenib—melanoma	0.00103	0.00979	CcSEcCtD
Ceftazidime—Infestation—Vemurafenib—melanoma	0.00103	0.00979	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00102	0.00971	CcSEcCtD
Ceftazidime—Ceftibuten—SLC15A2—melanoma	0.000989	0.157	CrCbGaD
Ceftazidime—Oral candidiasis—Docetaxel—melanoma	0.000985	0.00936	CcSEcCtD
Ceftazidime—Aplastic anaemia—Dactinomycin—melanoma	0.000977	0.00929	CcSEcCtD
Ceftazidime—Vaginal inflammation—Temozolomide—melanoma	0.000941	0.00895	CcSEcCtD
Ceftazidime—Phlebitis—Bleomycin—melanoma	0.00094	0.00894	CcSEcCtD
Ceftazidime—Skin exfoliation—Carmustine—melanoma	0.00093	0.00884	CcSEcCtD
Ceftazidime—Candida infection—Carmustine—melanoma	0.00093	0.00884	CcSEcCtD
Ceftazidime—Candida infection—Temozolomide—melanoma	0.000898	0.00854	CcSEcCtD
Ceftazidime—Skin exfoliation—Temozolomide—melanoma	0.000898	0.00854	CcSEcCtD
Ceftazidime—Coma—Carmustine—melanoma	0.00089	0.00846	CcSEcCtD
Ceftazidime—Vaginal infection—Temozolomide—melanoma	0.000888	0.00845	CcSEcCtD
Ceftazidime—Aplastic anaemia—Temozolomide—melanoma	0.000883	0.0084	CcSEcCtD
Ceftazidime—Phlebitis—Dactinomycin—melanoma	0.000877	0.00833	CcSEcCtD
Ceftazidime—Erythema multiforme—Vemurafenib—melanoma	0.000874	0.00831	CcSEcCtD
Ceftazidime—Dermatitis atopic—Docetaxel—melanoma	0.000845	0.00804	CcSEcCtD
Ceftazidime—Angiopathy—Vemurafenib—melanoma	0.000839	0.00797	CcSEcCtD
Ceftazidime—Phlebitis—Carmustine—melanoma	0.00082	0.0078	CcSEcCtD
Ceftazidime—Thrombophlebitis—Carmustine—melanoma	0.000816	0.00776	CcSEcCtD
Ceftazidime—Cefepime—SLC15A2—melanoma	0.000815	0.13	CrCbGaD
Ceftazidime—Thrombophlebitis—Temozolomide—melanoma	0.000789	0.0075	CcSEcCtD
Ceftazidime—Dysgeusia—Vemurafenib—melanoma	0.000788	0.00749	CcSEcCtD
Ceftazidime—Lethargy—Dactinomycin—melanoma	0.000771	0.00733	CcSEcCtD
Ceftazidime—Cefuroxime—SLC15A2—melanoma	0.000738	0.117	CrCbGaD
Ceftazidime—Hot flush—Temozolomide—melanoma	0.00073	0.00694	CcSEcCtD
Ceftazidime—Menopausal symptoms—Temozolomide—melanoma	0.000724	0.00688	CcSEcCtD
Ceftazidime—Bronchospasm—Bleomycin—melanoma	0.000688	0.00654	CcSEcCtD
Ceftazidime—Hyperbilirubinaemia—Docetaxel—melanoma	0.000688	0.00654	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00068	0.00647	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00068	0.00646	CcSEcCtD
Ceftazidime—Pancytopenia—Bleomycin—melanoma	0.000665	0.00632	CcSEcCtD
Ceftazidime—Anaphylactic shock—Vemurafenib—melanoma	0.000657	0.00624	CcSEcCtD
Ceftazidime—Inflammation—Docetaxel—melanoma	0.000645	0.00613	CcSEcCtD
Ceftazidime—Nervous system disorder—Vemurafenib—melanoma	0.000644	0.00612	CcSEcCtD
Ceftazidime—Skin disorder—Vemurafenib—melanoma	0.000638	0.00607	CcSEcCtD
Ceftazidime—Cefixime—SLC15A2—melanoma	0.000637	0.101	CrCbGaD
Ceftazidime—Pancytopenia—Dactinomycin—melanoma	0.00062	0.00589	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000615	0.00585	CcSEcCtD
Ceftazidime—Hypotension—Vemurafenib—melanoma	0.000614	0.00584	CcSEcCtD
Ceftazidime—Neutropenia—Dactinomycin—melanoma	0.00061	0.0058	CcSEcCtD
Ceftazidime—Colitis—Docetaxel—melanoma	0.000601	0.00571	CcSEcCtD
Ceftazidime—Skin exfoliation—Docetaxel—melanoma	0.000597	0.00568	CcSEcCtD
Ceftazidime—Candida infection—Docetaxel—melanoma	0.000597	0.00568	CcSEcCtD
Ceftazidime—Cefdinir—SLC15A2—melanoma	0.000588	0.0936	CrCbGaD
Ceftazidime—Cefaclor—SLC15A2—melanoma	0.000583	0.0928	CrCbGaD
Ceftazidime—Pancytopenia—Carmustine—melanoma	0.00058	0.00552	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000577	0.00549	CcSEcCtD
Ceftazidime—Neutropenia—Carmustine—melanoma	0.000571	0.00543	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Vemurafenib—melanoma	0.000567	0.00539	CcSEcCtD
Ceftazidime—Haemoglobin—Bleomycin—melanoma	0.000563	0.00535	CcSEcCtD
Ceftazidime—Pancytopenia—Temozolomide—melanoma	0.000561	0.00533	CcSEcCtD
Ceftazidime—Haemorrhage—Bleomycin—melanoma	0.00056	0.00533	CcSEcCtD
Ceftazidime—Neutropenia—Temozolomide—melanoma	0.000552	0.00525	CcSEcCtD
Ceftazidime—Agranulocytosis—Dactinomycin—melanoma	0.000543	0.00516	CcSEcCtD
Ceftazidime—Renal failure—Carmustine—melanoma	0.000535	0.00509	CcSEcCtD
Ceftazidime—Phlebitis—Docetaxel—melanoma	0.000527	0.00501	CcSEcCtD
Ceftazidime—Infestation NOS—Temozolomide—melanoma	0.000526	0.005	CcSEcCtD
Ceftazidime—Infestation—Temozolomide—melanoma	0.000526	0.005	CcSEcCtD
Ceftazidime—Thrombophlebitis—Docetaxel—melanoma	0.000525	0.00499	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000522	0.00496	CcSEcCtD
Ceftazidime—Flushing—Bleomycin—melanoma	0.00052	0.00494	CcSEcCtD
Ceftazidime—Body temperature increased—Vemurafenib—melanoma	0.000519	0.00494	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Temozolomide—melanoma	0.000498	0.00473	CcSEcCtD
Ceftazidime—Erythema multiforme—Dactinomycin—melanoma	0.000494	0.0047	CcSEcCtD
Ceftazidime—Haemoglobin—Carmustine—melanoma	0.000491	0.00467	CcSEcCtD
Ceftazidime—Haemorrhage—Carmustine—melanoma	0.000489	0.00465	CcSEcCtD
Ceftazidime—Hallucination—Carmustine—melanoma	0.000486	0.00463	CcSEcCtD
Ceftazidime—Hot flush—Docetaxel—melanoma	0.000486	0.00462	CcSEcCtD
Ceftazidime—Flushing—Dactinomycin—melanoma	0.000485	0.00461	CcSEcCtD
Ceftazidime—Hypersensitivity—Vemurafenib—melanoma	0.000484	0.0046	CcSEcCtD
Ceftazidime—Menopausal symptoms—Docetaxel—melanoma	0.000481	0.00458	CcSEcCtD
Ceftazidime—Renal impairment—Docetaxel—melanoma	0.000477	0.00454	CcSEcCtD
Ceftazidime—Haemoglobin—Temozolomide—melanoma	0.000475	0.00451	CcSEcCtD
Ceftazidime—Haemorrhage—Temozolomide—melanoma	0.000473	0.00449	CcSEcCtD
Ceftazidime—Hallucination—Temozolomide—melanoma	0.00047	0.00447	CcSEcCtD
Ceftazidime—Pruritus—Vemurafenib—melanoma	0.000465	0.00442	CcSEcCtD
Ceftazidime—Lethargy—Docetaxel—melanoma	0.000464	0.00441	CcSEcCtD
Ceftazidime—Cefotaxime—SLC15A2—melanoma	0.000461	0.0733	CrCbGaD
Ceftazidime—Ceftriaxone—SLC15A2—melanoma	0.000454	0.0723	CrCbGaD
Ceftazidime—Flushing—Carmustine—melanoma	0.000454	0.00431	CcSEcCtD
Ceftazidime—Diarrhoea—Vemurafenib—melanoma	0.000449	0.00427	CcSEcCtD
Ceftazidime—Erythema multiforme—Temozolomide—melanoma	0.000447	0.00425	CcSEcCtD
Ceftazidime—Flushing—Temozolomide—melanoma	0.000439	0.00417	CcSEcCtD
Ceftazidime—Leukopenia—Bleomycin—melanoma	0.000436	0.00415	CcSEcCtD
Ceftazidime—Dizziness—Vemurafenib—melanoma	0.000434	0.00413	CcSEcCtD
Ceftazidime—Angiopathy—Temozolomide—melanoma	0.000429	0.00408	CcSEcCtD
Ceftazidime—Immune system disorder—Temozolomide—melanoma	0.000427	0.00406	CcSEcCtD
Ceftazidime—Vomiting—Vemurafenib—melanoma	0.000418	0.00397	CcSEcCtD
Ceftazidime—Rash—Vemurafenib—melanoma	0.000414	0.00394	CcSEcCtD
Ceftazidime—Dermatitis—Vemurafenib—melanoma	0.000414	0.00393	CcSEcCtD
Ceftazidime—Headache—Vemurafenib—melanoma	0.000411	0.00391	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000409	0.00389	CcSEcCtD
Ceftazidime—Leukopenia—Dactinomycin—melanoma	0.000407	0.00387	CcSEcCtD
Ceftazidime—Dysgeusia—Temozolomide—melanoma	0.000403	0.00383	CcSEcCtD
Ceftazidime—Vision blurred—Carmustine—melanoma	0.000401	0.00381	CcSEcCtD
Ceftazidime—Tremor—Carmustine—melanoma	0.000399	0.00379	CcSEcCtD
Ceftazidime—Anaphylactic shock—Bleomycin—melanoma	0.000398	0.00378	CcSEcCtD
Ceftazidime—Cefalotin—SLC15A2—melanoma	0.000398	0.0633	CrCbGaD
Ceftazidime—Agitation—Carmustine—melanoma	0.000391	0.00372	CcSEcCtD
Ceftazidime—Nausea—Vemurafenib—melanoma	0.00039	0.00371	CcSEcCtD
Ceftazidime—Thrombocytopenia—Bleomycin—melanoma	0.00039	0.0037	CcSEcCtD
Ceftazidime—Vision blurred—Temozolomide—melanoma	0.000388	0.00369	CcSEcCtD
Ceftazidime—Bronchospasm—Docetaxel—melanoma	0.000386	0.00367	CcSEcCtD
Ceftazidime—Tremor—Temozolomide—melanoma	0.000385	0.00366	CcSEcCtD
Ceftazidime—Leukopenia—Carmustine—melanoma	0.000381	0.00362	CcSEcCtD
Ceftazidime—Agitation—Temozolomide—melanoma	0.000378	0.00359	CcSEcCtD
Ceftazidime—Angioedema—Temozolomide—melanoma	0.000376	0.00357	CcSEcCtD
Ceftazidime—Pancytopenia—Docetaxel—melanoma	0.000373	0.00354	CcSEcCtD
Ceftazidime—Hypotension—Bleomycin—melanoma	0.000372	0.00354	CcSEcCtD
Ceftazidime—Convulsion—Carmustine—melanoma	0.000369	0.00351	CcSEcCtD
Ceftazidime—Leukopenia—Temozolomide—melanoma	0.000368	0.0035	CcSEcCtD
Ceftazidime—Neutropenia—Docetaxel—melanoma	0.000367	0.00349	CcSEcCtD
Ceftazidime—Thrombocytopenia—Dactinomycin—melanoma	0.000363	0.00345	CcSEcCtD
Ceftazidime—Cephalexin—SLC15A2—melanoma	0.000362	0.0575	CrCbGaD
Ceftazidime—Paraesthesia—Bleomycin—melanoma	0.000357	0.0034	CcSEcCtD
Ceftazidime—Convulsion—Temozolomide—melanoma	0.000356	0.00339	CcSEcCtD
Ceftazidime—Infestation NOS—Docetaxel—melanoma	0.00035	0.00333	CcSEcCtD
Ceftazidime—Infestation—Docetaxel—melanoma	0.00035	0.00333	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000348	0.00331	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000347	0.0033	CcSEcCtD
Ceftazidime—Renal failure—Docetaxel—melanoma	0.000344	0.00327	CcSEcCtD
Ceftazidime—Jaundice—Docetaxel—melanoma	0.000341	0.00324	CcSEcCtD
Ceftazidime—Pain—Bleomycin—melanoma	0.00034	0.00324	CcSEcCtD
Ceftazidime—Thrombocytopenia—Carmustine—melanoma	0.00034	0.00323	CcSEcCtD
Ceftazidime—Anaphylactic shock—Temozolomide—melanoma	0.000336	0.00319	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Docetaxel—melanoma	0.000331	0.00315	CcSEcCtD
Ceftazidime—Nervous system disorder—Temozolomide—melanoma	0.000329	0.00313	CcSEcCtD
Ceftazidime—Thrombocytopenia—Temozolomide—melanoma	0.000329	0.00312	CcSEcCtD
Ceftazidime—Agranulocytosis—Docetaxel—melanoma	0.000327	0.00311	CcSEcCtD
Ceftazidime—Skin disorder—Temozolomide—melanoma	0.000326	0.0031	CcSEcCtD
Ceftazidime—Hypotension—Carmustine—melanoma	0.000325	0.00309	CcSEcCtD
Ceftazidime—Pain—Dactinomycin—melanoma	0.000317	0.00302	CcSEcCtD
Ceftazidime—Urticaria—Bleomycin—melanoma	0.000316	0.00301	CcSEcCtD
Ceftazidime—Haemoglobin—Docetaxel—melanoma	0.000316	0.003	CcSEcCtD
Ceftazidime—Body temperature increased—Bleomycin—melanoma	0.000315	0.00299	CcSEcCtD
Ceftazidime—Haemorrhage—Docetaxel—melanoma	0.000314	0.00299	CcSEcCtD
Ceftazidime—Paraesthesia—Carmustine—melanoma	0.000312	0.00297	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Dactinomycin—melanoma	0.000304	0.00289	CcSEcCtD
Ceftazidime—Paraesthesia—Temozolomide—melanoma	0.000301	0.00287	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Carmustine—melanoma	0.0003	0.00285	CcSEcCtD
Ceftazidime—Erythema multiforme—Docetaxel—melanoma	0.000297	0.00282	CcSEcCtD
Ceftazidime—Pain—Carmustine—melanoma	0.000297	0.00282	CcSEcCtD
Ceftazidime—Abdominal pain—Dactinomycin—melanoma	0.000293	0.00279	CcSEcCtD
Ceftazidime—Body temperature increased—Dactinomycin—melanoma	0.000293	0.00279	CcSEcCtD
Ceftazidime—Hypersensitivity—Bleomycin—melanoma	0.000293	0.00279	CcSEcCtD
Ceftazidime—Flushing—Docetaxel—melanoma	0.000292	0.00277	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Temozolomide—melanoma	0.00029	0.00276	CcSEcCtD
Ceftazidime—Pain—Temozolomide—melanoma	0.000287	0.00273	CcSEcCtD
Ceftazidime—Angiopathy—Docetaxel—melanoma	0.000285	0.00271	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Carmustine—melanoma	0.000284	0.0027	CcSEcCtD
Ceftazidime—Immune system disorder—Docetaxel—melanoma	0.000284	0.0027	CcSEcCtD
Ceftazidime—Pruritus—Bleomycin—melanoma	0.000282	0.00268	CcSEcCtD
Ceftazidime—Body temperature increased—Carmustine—melanoma	0.000275	0.00261	CcSEcCtD
Ceftazidime—Abdominal pain—Carmustine—melanoma	0.000275	0.00261	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Temozolomide—melanoma	0.000275	0.00261	CcSEcCtD
Ceftazidime—Hypersensitivity—Dactinomycin—melanoma	0.000273	0.0026	CcSEcCtD
Ceftazidime—Dysgeusia—Docetaxel—melanoma	0.000268	0.00255	CcSEcCtD
Ceftazidime—Urticaria—Temozolomide—melanoma	0.000267	0.00254	CcSEcCtD
Ceftazidime—Abdominal pain—Temozolomide—melanoma	0.000265	0.00252	CcSEcCtD
Ceftazidime—Body temperature increased—Temozolomide—melanoma	0.000265	0.00252	CcSEcCtD
Ceftazidime—Hypersensitivity—Carmustine—melanoma	0.000256	0.00243	CcSEcCtD
Ceftazidime—Diarrhoea—Dactinomycin—melanoma	0.000254	0.00241	CcSEcCtD
Ceftazidime—Vomiting—Bleomycin—melanoma	0.000253	0.00241	CcSEcCtD
Ceftazidime—Rash—Bleomycin—melanoma	0.000251	0.00239	CcSEcCtD
Ceftazidime—Dermatitis—Bleomycin—melanoma	0.000251	0.00238	CcSEcCtD
Ceftazidime—Hypersensitivity—Temozolomide—melanoma	0.000247	0.00235	CcSEcCtD
Ceftazidime—Leukopenia—Docetaxel—melanoma	0.000245	0.00233	CcSEcCtD
Ceftazidime—Diarrhoea—Carmustine—melanoma	0.000238	0.00226	CcSEcCtD
Ceftazidime—Pruritus—Temozolomide—melanoma	0.000238	0.00226	CcSEcCtD
Ceftazidime—Convulsion—Docetaxel—melanoma	0.000237	0.00225	CcSEcCtD
Ceftazidime—Nausea—Bleomycin—melanoma	0.000236	0.00225	CcSEcCtD
Ceftazidime—Vomiting—Dactinomycin—melanoma	0.000236	0.00224	CcSEcCtD
Ceftazidime—Rash—Dactinomycin—melanoma	0.000234	0.00222	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000231	0.0022	CcSEcCtD
Ceftazidime—Dizziness—Carmustine—melanoma	0.00023	0.00218	CcSEcCtD
Ceftazidime—Diarrhoea—Temozolomide—melanoma	0.00023	0.00218	CcSEcCtD
Ceftazidime—Anaphylactic shock—Docetaxel—melanoma	0.000223	0.00212	CcSEcCtD
Ceftazidime—Dizziness—Temozolomide—melanoma	0.000222	0.00211	CcSEcCtD
Ceftazidime—Vomiting—Carmustine—melanoma	0.000221	0.0021	CcSEcCtD
Ceftazidime—Nausea—Dactinomycin—melanoma	0.00022	0.0021	CcSEcCtD
Ceftazidime—Rash—Carmustine—melanoma	0.000219	0.00208	CcSEcCtD
Ceftazidime—Nervous system disorder—Docetaxel—melanoma	0.000219	0.00208	CcSEcCtD
Ceftazidime—Dermatitis—Carmustine—melanoma	0.000219	0.00208	CcSEcCtD
Ceftazidime—Thrombocytopenia—Docetaxel—melanoma	0.000219	0.00208	CcSEcCtD
Ceftazidime—Headache—Carmustine—melanoma	0.000218	0.00207	CcSEcCtD
Ceftazidime—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.000217	0.355	CbGpPWpGaD
Ceftazidime—Skin disorder—Docetaxel—melanoma	0.000217	0.00206	CcSEcCtD
Ceftazidime—Vomiting—Temozolomide—melanoma	0.000213	0.00203	CcSEcCtD
Ceftazidime—Rash—Temozolomide—melanoma	0.000212	0.00201	CcSEcCtD
Ceftazidime—Dermatitis—Temozolomide—melanoma	0.000211	0.00201	CcSEcCtD
Ceftazidime—Headache—Temozolomide—melanoma	0.00021	0.002	CcSEcCtD
Ceftazidime—Hypotension—Docetaxel—melanoma	0.000209	0.00198	CcSEcCtD
Ceftazidime—Nausea—Carmustine—melanoma	0.000206	0.00196	CcSEcCtD
Ceftazidime—Paraesthesia—Docetaxel—melanoma	0.0002	0.00191	CcSEcCtD
Ceftazidime—Nausea—Temozolomide—melanoma	0.000199	0.0019	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Docetaxel—melanoma	0.000193	0.00183	CcSEcCtD
Ceftazidime—Pain—Docetaxel—melanoma	0.000191	0.00181	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Docetaxel—melanoma	0.000183	0.00174	CcSEcCtD
Ceftazidime—Body temperature increased—Docetaxel—melanoma	0.000176	0.00168	CcSEcCtD
Ceftazidime—Abdominal pain—Docetaxel—melanoma	0.000176	0.00168	CcSEcCtD
Ceftazidime—Hypersensitivity—Docetaxel—melanoma	0.000164	0.00156	CcSEcCtD
Ceftazidime—Pruritus—Docetaxel—melanoma	0.000158	0.0015	CcSEcCtD
Ceftazidime—Diarrhoea—Docetaxel—melanoma	0.000153	0.00145	CcSEcCtD
Ceftazidime—Dizziness—Docetaxel—melanoma	0.000148	0.0014	CcSEcCtD
Ceftazidime—Vomiting—Docetaxel—melanoma	0.000142	0.00135	CcSEcCtD
Ceftazidime—Rash—Docetaxel—melanoma	0.000141	0.00134	CcSEcCtD
Ceftazidime—Dermatitis—Docetaxel—melanoma	0.000141	0.00134	CcSEcCtD
Ceftazidime—Headache—Docetaxel—melanoma	0.00014	0.00133	CcSEcCtD
Ceftazidime—Nausea—Docetaxel—melanoma	0.000133	0.00126	CcSEcCtD
Ceftazidime—Ceftriaxone—ALB—melanoma	9.78e-05	0.0156	CrCbGaD
Ceftazidime—Cefalotin—ALB—melanoma	8.56e-05	0.0136	CrCbGaD
Ceftazidime—Cephalexin—ALB—melanoma	7.78e-05	0.0124	CrCbGaD
Ceftazidime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	3.04e-05	0.0496	CbGpPWpGaD
Ceftazidime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	2.93e-05	0.0478	CbGpPWpGaD
Ceftazidime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	2.82e-05	0.046	CbGpPWpGaD
Ceftazidime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	1.79e-05	0.0292	CbGpPWpGaD
Ceftazidime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	1.72e-05	0.0281	CbGpPWpGaD
Ceftazidime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	1.66e-05	0.0271	CbGpPWpGaD
Ceftazidime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	1.46e-05	0.0238	CbGpPWpGaD
Ceftazidime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	1.26e-05	0.0206	CbGpPWpGaD
Ceftazidime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	1.17e-05	0.0191	CbGpPWpGaD
Ceftazidime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	1.1e-05	0.018	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ABCB5—melanoma	8.03e-06	0.0131	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	7.99e-06	0.013	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	7.71e-06	0.0126	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC15A2—melanoma	7.58e-06	0.0124	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	7.45e-06	0.0122	CbGpPWpGaD
Ceftazidime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	7.43e-06	0.0121	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	7.42e-06	0.0121	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ABCB5—melanoma	7.33e-06	0.012	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC17A5—melanoma	7.29e-06	0.0119	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	7.26e-06	0.0118	CbGpPWpGaD
Ceftazidime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	6.89e-06	0.0113	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	6.74e-06	0.011	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC6A11—melanoma	6.62e-06	0.0108	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—melanoma	5.72e-06	0.00934	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	5.57e-06	0.00909	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ABCB5—melanoma	5.53e-06	0.00903	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC17A5—melanoma	5.51e-06	0.00899	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	5.17e-06	0.00843	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ARL2—melanoma	5.08e-06	0.0083	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC6A11—melanoma	5e-06	0.00816	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	4.06e-06	0.00663	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	3.92e-06	0.00639	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC15A2—melanoma	3.85e-06	0.00629	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ARL2—melanoma	3.84e-06	0.00626	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	3.77e-06	0.00615	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC17A5—melanoma	3.71e-06	0.00605	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	3.69e-06	0.00602	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	3.42e-06	0.00559	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC6A11—melanoma	3.37e-06	0.0055	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	3.32e-06	0.00542	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	3.08e-06	0.00503	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—melanoma	3.03e-06	0.00495	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC15A2—melanoma	2.91e-06	0.00475	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC17A5—melanoma	2.8e-06	0.00457	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC6A11—melanoma	2.54e-06	0.00415	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—melanoma	2.29e-06	0.00373	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	1.69e-06	0.00275	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	1.58e-06	0.00258	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.57e-06	0.00256	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC5A5—melanoma	1.54e-06	0.00251	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	1.47e-06	0.0024	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—ALB—melanoma	1.44e-06	0.00236	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	1.29e-06	0.0021	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	1.19e-06	0.00195	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ABCB1—melanoma	1.17e-06	0.00192	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC5A5—melanoma	1.16e-06	0.0019	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—ALB—melanoma	1.09e-06	0.00178	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ABCB1—melanoma	8.86e-07	0.00145	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	8.04e-07	0.00131	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	7.47e-07	0.00122	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ALB—melanoma	7.34e-07	0.0012	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ALB—melanoma	5.54e-07	0.000905	CbGpPWpGaD
